{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:40:01Z","timestamp":1781934001760,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jhin.2019.09.011","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T11:13:56Z","timestamp":1568891636000},"page":"125-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Role of antimicrobial restrictions in bacterial resistance control: a systematic literature review"],"prefix":"10.1016","volume":"104","author":[{"given":"M.","family":"Chatzopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2019.09.011_bib1","series-title":"Ten threats to global health in 2019","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.jhin.2019.09.011_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/14656566.9.4.561","article-title":"The role of carbapenems in the treatment of severe nosocomial respiratory tract infections","volume":"9","author":"Joseph","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jhin.2019.09.011_bib3","author":"Centers for Disease Prevention and Control"},{"key":"10.1016\/j.jhin.2019.09.011_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib5","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/ciw217","article-title":"Executive summary: implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1086\/500319","article-title":"Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study","volume":"42","author":"Charbonneau","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jhin.2011.03.008","article-title":"Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis","volume":"78","author":"Parienti","year":"2011","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2019.09.011_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/503016","article-title":"Limiting the emergence of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions","volume":"27","author":"Lipworth","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2019.09.011_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10156-006-0452-0","article-title":"Impact of ceftazidime restriction on Gram-negative bacterial resistance in an intensive care unit","volume":"12","author":"Brahmi","year":"2006","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s13312-010-0118-y","article-title":"Restriction of cephalosporins and control of extended spectrum beta-lactamase producing Gram negative bacteria in a neonatal intensive care unit","volume":"47","author":"Murki","year":"2010","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jhin.2019.09.011_bib11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/01.CCM.0000059315.07526.DA","article-title":"Restriction of third-generation cephalosporin use decreases infection-related mortality","volume":"31","author":"Du","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhin.2019.09.011_bib12","first-page":"633","article-title":"Impact of limited cephalosporin use on prevalence of methicillin-resistant Staphylococcus aureus in the intensive care unit","volume":"21","author":"Bassetti","year":"2009","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/AAC.43.4.882","article-title":"Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin","volume":"43","author":"Lister","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhin.2019.09.011_bib15","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1093\/ofid\/ofy209.040","article-title":"855. Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals","volume":"5","author":"Yarrington","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib16","first-page":"457","article-title":"Antimicrobial stewardship stabilizes resistance patterns in a behavioral health setting","volume":"71","author":"Freedman","year":"2007","journal-title":"Conn Med"},{"key":"10.1016\/j.jhin.2019.09.011_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2125.2011.04161.x","article-title":"The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings","volume":"74","author":"Aldeyab","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jhin.2019.09.011_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/phar.1590","article-title":"Impact of a stewardship-initiated restriction on empirical use of ciprofloxacin on nonsusceptibility of Escherichia coli urinary isolates to ciprofloxacin","volume":"35","author":"O\u2019Brien","year":"2015","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.jhin.2019.09.011_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jhin.2019.09.011_bib20","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/AAC.44.6.1428-1437.2000","article-title":"Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin","volume":"44","author":"Bisognano","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099101","article-title":"Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship","volume":"9","author":"Yoon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhin.2019.09.011_bib22","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dku471","article-title":"Impact of ertapenem on antimicrobial resistance in a sentinel group of Gram-negative bacilli: a 6 year antimicrobial resistance surveillance study","volume":"70","author":"Rodriguez-Osorio","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1086\/596781","article-title":"The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem \u2013 a hospital case study","volume":"30","author":"Lima","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2019.09.011_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/IDR.S22491","article-title":"Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital","volume":"4","author":"Oliveira","year":"2011","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jhin.2019.09.011_bib25","first-page":"1","article-title":"Carbapenem stewardship \u2013 positive impact on hospital ecology","volume":"15","author":"Lima","year":"2011","journal-title":"Brazilian J Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/jac\/dki009","article-title":"Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems","volume":"55","author":"Livermore","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib27","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1128\/AAC.01535-08","article-title":"Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa","volume":"53","author":"Pakyz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib28","author":"Center for Disease Prevention and Control"},{"key":"10.1016\/j.jhin.2019.09.011_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhin.2015.05.006","article-title":"Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time series analysis","volume":"91","author":"Sarma","year":"2015","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2019.09.011_bib30","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/jac\/dkw055","article-title":"Impact of antibiotic restriction on resistance levels of Escherichia coli\u202f: a controlled interrupted time series study of a hospital-wide antibiotic stewardship programme","volume":"71","author":"Boel","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/clinids\/23.5.1020","article-title":"Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci","volume":"23","author":"Quale","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib32","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/514743","article-title":"Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary","volume":"28","author":"Landman","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/346153","article-title":"Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins","volume":"36","author":"Lautenbach","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s12879-016-2051-8","article-title":"Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center","volume":"16","author":"Ma","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jmii.2015.05.011","article-title":"Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common Gram-negative bacilli causing health care-associated infections: a multicenter comparison","volume":"49","author":"Lai","year":"2016","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jhin.2019.09.011_bib36","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1128\/JCM.36.7.1938-1941.1998","article-title":"Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates","volume":"36","author":"Jawad","year":"1998","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhin.2019.09.011_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jhin.2019.09.011_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1590\/S1413-86702007000200022","article-title":"Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit","volume":"11","author":"de Araujo","year":"2007","journal-title":"Brazilian J Infect Dis"},{"key":"10.1016\/j.jhin.2019.09.011_bib39","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/jac\/dkw179","article-title":"Impact of the PROVAUR stewardship programme on linezolid resistance in a tertiary university hospital: a before-and-after interventional study","volume":"71","author":"Garc\u00eda-Mart\u00ednez","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1017\/S0950268813001374","article-title":"Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings","volume":"142","author":"Aldeyab","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jhin.2019.09.011_bib41","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","article-title":"Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital","volume":"280","author":"Rahal","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jhin.2019.09.011_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijantimicag.2006.08.042","article-title":"Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin\/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital","volume":"29","author":"Petrikkos","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhin.2019.09.011_bib43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00006454-200003000-00005","article-title":"Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country","volume":"19","author":"S\u00e1ez-Llorens","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jhin.2019.09.011_bib44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/dkh163","article-title":"Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram","volume":"53","author":"Cook","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2019.09.011_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7150\/ijms.8.339","article-title":"The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey","volume":"8","author":"Altunsoy","year":"2011","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jhin.2019.09.011_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1592\/phco.23.5.618.32197","article-title":"The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to beta-lactams in a large teaching hospital","volume":"23","author":"Regal","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhin.2019.09.011_bib47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jmii.2015.10.006","article-title":"Decreased antimicrobial resistance and defined daily doses after implementation of a clinical culture-guided antimicrobial stewardship program in a local hospital","volume":"50","author":"Wu","year":"2017","journal-title":"J\u00a0Microbiol Immunol Infect"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670119303998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670119303998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:14:25Z","timestamp":1759292065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670119303998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0195670119303998"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2019.09.011","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of antimicrobial restrictions in bacterial resistance control: a systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2019.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}